FDA Panel Raises Concerns About Labeling, Abuse Of Oral NRT Spray

An FDA advisory committee on Wednesday (Sept. 18) supported the over-the-counter use of a proposed nicotine oral spray for smoking cessation by a vote of nine to six, but many of the committee members raised concerns about potential youth abuse of the product and said the labeling may not be adequate for OTC use. GlaxoSmithKline’s proposed Nicorette QuickMist is currently marketed in 45 other countries, 25 of which allow it to be marketed for self-selection, which is similar to OTC...